Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

As Chemist Warehouse celebrates the $32 billion marriage with Sigma, it’s clear how vital the retail chain’s culture will be ...

We believe these judges are acting as judicial activists rather than honest arbiters of the law,” press secretary Karoline ...

The S&P/ASX 200 closed 51.3 points higher, up 0.61%. Well received December quarter results from Commonwealth Bank of ...

Wednesday's will be the last inflation reading before any direct impact from U.S. President Donald Trump's tariff measures, which went into effect this month.

Royalty Receipts grew 12% to $729 million in the fourth quarter and 13% to $2,771 million for full year 2024, driven by strong performance from ...

Let’s accept the fact that we are likely to be dealing with volatility for the next four years. Both in the real world and in ...

Barron Trump made his first public appearance at New York University since his father Donald Trump's massive election win and ...